Access to new TB drugs - World TB Day 2017

Filmed in MSF TB projects this short web video highlights MSF advocacy directed at broadening access to new TB drugs.

MSF186677

If you think this image is in any way inappropriate, please report it, by including its URN/identifying code and a brief description of your concern in sending an email to [email protected]

Linked assets

Access to new TB drugs - World TB Day 2017_RU

Subt. Russian

World TB Day - 24 March 2017

Access to new TB drugs - World TB Day 2017 - International - Square

Access to new TB drugs - World TB Day 2017 - International

Subt. English

Access to new TB drugs - World TB Day 2017 / GERMAN -- Square

Subt. German

Access to new TB drugs - World TB Day 2017 / GERMAN

Subt. German

Add to lightbox

Add to cart

Unique Identifier Code / URN MSF186677

Date taken / Date Recorded 15/05/2017 12:00 AM

Country Multiple

Commissioning section MSF ACCESS CAMPAIGN

Usage Rights (MSF) External Media, MSF Fundraising, MSF Publications, Social Media

Formal Consent Copy available no

Editor's rating ★★★★★ (C)

Video format h264 (Main) (avc1 / 0x31637661)

Duration 1m22s

Maximum Size 1920px × 1080px 133.87 MB

Additional Information / Shotlist TB is Real.

Tuberculosis kills 1.8 million people each year.

That’s more than any other infectious disease.

Drug-resistant TB is particularly hard to treat using current medicines.

Patients have to take large numbers of pills, and face daily injections, for up to two years.

Side effects can include: Permanent deafness, nausea and vomiting, blindness and psychosis

Five years ago, two new TB medicines were introduced.

They have far fewer side effects, and are much more powerful.

However most patients are denied access to the new medicines and are stuck with the old medicines.

This needs to change.

Pharmaceutical companies need to register the medicines and make them affordable in all the

countries where they are needed.

And governments need to include the new medicines in their treatment guidelines

to ensure patients are given a better chance.

MSF is campaigning hard to speed up access to the new medicines.

Because for patients with drug-resistant TB, it’s a matter of life or death.

Special instructions Released as part of the MSF Aceess Campaign World TB Day - 24 March 2017

Keywords

Access to Medicines

Multidrug-Resistant Tuberculosis

Tuberculosis